Literature DB >> 7487981

Expression of local hepatocyte growth factor system in vascular tissues.

Y Nakamura1, R Morishita, J Higaki, I Kida, M Aoki, A Moriguchi, K Yamada, S Hayashi, Y Yo, K Matsumoto.   

Abstract

Since endothelial cells (EC) are known to secrete various anti-proliferative and vasodilating factors, an agent that promotes seeding or regeneration of EC may have potential therapeutic value against vascular smooth muscle cell (VSMC) proliferation. For the above purpose, we have found that hepatocyte growth factor (HGF) fulfills such conditions. However, the local HGF system has not yet clarified. Therefore, we investigated endogenous HGF production and its specific receptor (c-met) in vascular tissues. Our results revealed the expressions of HGF and its receptor (c-met) mRNA in endothelial cells, VSMC and neointimal VSMC of rat assessed by RT-PCR. HGF and c-met mRNA were also detected in human aortic endothelial cells and VSMC. Endothelial cells and VSMC of both rat and human produce and secrete immunoreactive HGF as assessed by ELISA. Of importance, the existence of local HGF system (HGF and c-met) was also observed in vivo in intact abdominal aorta of SD and Wistar rats. Overall, this study demonstrated that HGF is expressed and secreted from endothelial cells and VSMC of both rat and human in vitro as well as in vivo. Since HGF has characteristics of an endothelium-specific growth factor, locally synthesized HGF in endothelial cells and VSMC may have a role in vascular functions in autocrine-paracrine manner.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7487981     DOI: 10.1006/bbrc.1995.2490

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  20 in total

Review 1.  Advances in gene therapy of liver cirrhosis: a review.

Authors:  W J Dai; H C Jiang
Journal:  World J Gastroenterol       Date:  2001-02       Impact factor: 5.742

2.  Hepatocyte growth factor enhances vascular endothelial growth factor-induced angiogenesis in vitro and in vivo.

Authors:  X Xin; S Yang; G Ingle; C Zlot; L Rangell; J Kowalski; R Schwall; N Ferrara; M E Gerritsen
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

3.  Hepatocyte growth factor preferentially activates the anti-inflammatory arm of NF-κB signaling to induce A20 and protect renal proximal tubular epithelial cells from inflammation.

Authors:  Cleide G da Silva; Elizabeth R Maccariello; Szuhuei Wu Wilson; Prabhakar Putheti; Soizic Daniel; Scott M Damrauer; Clayton R Peterson; Jeffrey J Siracuse; Elzbieta Kaczmarek; Christiane Ferran
Journal:  J Cell Physiol       Date:  2012-04       Impact factor: 6.384

Review 4.  Scatter factor/hepatocyte growth factor in brain tumor growth and angiogenesis.

Authors:  Roger Abounader; John Laterra
Journal:  Neuro Oncol       Date:  2005-10       Impact factor: 12.300

Review 5.  Role of kidney biomarkers of chronic kidney disease: An update.

Authors:  Zeba Khan; Manoj Pandey
Journal:  Saudi J Biol Sci       Date:  2014-07-15       Impact factor: 4.219

6.  Comparison of the levels of hepatocyte growth factor and vascular endothelial growth factor in aqueous fluid and serum with grades of retinopathy in patients with diabetes mellitus.

Authors:  K Shinoda; S Ishida; S Kawashima; T Wakabayashi; T Matsuzaki; M Takayama; K Shinmura; M Yamada
Journal:  Br J Ophthalmol       Date:  1999-07       Impact factor: 4.638

7.  Production of hepatocyte growth factor during acute myocardial infarction.

Authors:  Y Zhu; Y Hojo; U Ikeda; K Shimada
Journal:  Heart       Date:  2000-04       Impact factor: 5.994

Review 8.  The role of platelets in tumour growth.

Authors:  K Pilatova; L Zdrazilova-Dubska; G L Klement
Journal:  Klin Onkol       Date:  2012

Review 9.  Hepatocyte growth factor, a biomarker of macroangiopathy in diabetes mellitus.

Authors:  Hiroyuki Konya; Masayuki Miuchi; Kahori Satani; Satoshi Matsutani; Taku Tsunoda; Yuzo Yano; Tomoyuki Katsuno; Tomoya Hamaguchi; Jun-Ichiro Miyagawa; Mitsuyoshi Namba
Journal:  World J Diabetes       Date:  2014-10-15

10.  UDP-sugar substrates of HAS3 regulate its O-GlcNAcylation, intracellular traffic, extracellular shedding and correlate with melanoma progression.

Authors:  Ashik Jawahar Deen; Uma Thanigai Arasu; Sanna Pasonen-Seppänen; Antti Hassinen; Piia Takabe; Sara Wojciechowski; Riikka Kärnä; Kirsi Rilla; Sakari Kellokumpu; Raija Tammi; Markku Tammi; Sanna Oikari
Journal:  Cell Mol Life Sci       Date:  2016-02-16       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.